Plasma Levels of Oxidative Stress Markers, before and after <i>BoNT/A</i> Treatment, in Chronic Migraine

Plasma Levels of Oxidative Stress Markers, before and after <i>BoNT/A</i> Treatment, in Chronic Migraine

The pathophysiological mechanisms of migraine transformation are debated. Modifications of plasma oxidative stress biomarkers have been described in chronic migraine. OnabotulintoxinA (BoNT/A) treatment, approved for chronic migraine prophylaxis, possibly reduces pain neurotransmitters release and o...

Full description

Bibliographic Details
Main Authors:	Elisa Dini, Sonia Mazzucchi, Ciro De Luca, Martina Cafalli, Lucia Chico, Annalisa Lo Gerfo, Gabriele Siciliano, Ubaldo Bonuccelli, Filippo Baldacci, Sara Gori
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Toxins
Subjects:	migraine chronic migraine medication overuse headache bont/a oxidative stress biomarkers
Online Access:	https://www.mdpi.com/2072-6651/11/10/608

Similar Items

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
by: Paolo Martelletti
Published: (2018-01-01)

Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay
by: Ilenia Drigo, et al.
Published: (2021-12-01)

Degradation of endocannabinoids in chronic migraine and medication overuse headache
by: L.M. Cupini, et al.
Published: (2008-05-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
by: Stephen D. Silberstein, et al.
Published: (2020-09-01)

Differences in Frontal Lobe Dysfunction in Patients with Episodic and Chronic Migraine
by: Sang-Hwa Lee, et al.
Published: (2021-06-01)

Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease
by: Ciro De Luca, et al.
Published: (2021-02-01)

Identifying and managing refractory migraine: barriers and opportunities?
by: Linda D’Antona, et al.
Published: (2019-08-01)

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
by: Todd J. Schwedt, et al.
Published: (2018-05-01)

Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
by: Hida Nierenburg, et al.
Published: (2020-07-01)

Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire
by: Alberto Raggi, et al.
Published: (2018-09-01)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
by: Sara Bottiroli, et al.
Published: (2018-05-01)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01)

Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study
by: Yen-Feng Wang, et al.
Published: (2021-05-01)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
by: Rosaria Greco, et al.
Published: (2020-10-01)

Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
by: Karin Zebenholzer, et al.
Published: (2018-05-01)

Medication-overuse headache. Retrospective comparison of preventive treatments
by: Abouch V. Krymchantowski, et al.

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
by: Sabina Cevoli, et al.
Published: (2017-05-01)

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
by: Edoardo Caronna, et al.
Published: (2021-10-01)

Erenumab in Mechanism-based Migraine Treatment
by: Aynur Özge, et al.
Published: (2021-09-01)

Current Perspective on Retinal Migraine
by: Yu Jeat Chong, et al.
Published: (2021-08-01)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
by: Simona Sacco, et al.
Published: (2021-05-01)

Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine
by: David Moreno-Ajona, et al.
Published: (2020-09-01)

European headache federation consensus on the definition of resistant and refractory migraine
by: Simona Sacco, et al.
Published: (2020-06-01)

Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice
by: Thays Crosara Abrahão Cunha, et al.
Published: (2021-11-01)

Vestibular migraine
by: Santosh Kumar Swain, et al.
Published: (2021-01-01)

Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
by: Abouch V. Krymchantowski, et al.
Published: (2016-08-01)

Advances in genetics of migraine
by: Heidi G. Sutherland, et al.
Published: (2019-06-01)

Effects of Behavioral Migraine Management Treatment and Preventative Drug Therapy on Positive Psychological and Palliative Migraine Management in Frequent Migraine
by: Huckins, Jamie L.
Published: (2009)

Machine learning approach to predict medication overuse in migraine patients
by: Patrizia Ferroni, et al.
Published: (2020-01-01)

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
by: Michail Vikelis, et al.
Published: (2017-05-01)

Pediatric Episodic Migraine with Aura: A Unique Entity?
by: Hannah F.J. Shapiro, et al.
Published: (2021-03-01)

Temperament concomitants of migraine
by: Warr, Natalie Beverley
Published: (2008)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
by: Willem Sebastiaan van Hoogstraten, et al.
Published: (2019-05-01)

Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment
by: Francesca Schiano di Cola, et al.
Published: (2019-07-01)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
by: Carlo Baraldi, et al.
Published: (2021-04-01)

Review of Prevention for Pediatric and Adolescent Migraine
by: William Qubty, et al.
Published: (2016-03-01)

‘Possessed’: Acute Confusional Migraine in an Adolescent, Prevented by Topiramate
by: Eugenia Rota, et al.
Published: (2012-12-01)

Transcranial Direct Current Stimulation and Migraine—The Beginning of a Long Journey
by: Samar S. Ayache, et al.
Published: (2020-04-01)

Cannot write session to /tmp/vufind_sessions/sess_bvcm6kaj07p093h6omov4i8bgf